, opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial ...
Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to ...
(Reuters) - French drugmaker Sanofi (NASDAQ:SNY) on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects ...